title: Epitope distribution in ordered and disordered protein regions. Part B - Ordered regions and disordered binding sites are targets of T- and B-cell immunity.
abstract: Intrinsically disordered proteins exist in highly flexible conformational states linked to different protein functions. In this work, we have presented evidence that HLA class-I- and class-II-binding T-cell epitopes, experimentally verified in several tumor-associated antigens and nuclear systemic autoantigens, are predominantly located in ordered protein regions or at disorder/order borderlines, defined by the majority of analyzed publicly available disorder predictors. We have also observed the overlapping of secondary structural elements and prevalently hydrophobic regions with T-cell epitopes in Epstein Barr Virus (EBV) nuclear antigen 1 (EBNA-1), cancer/testis antigen MAGE-A4, and Sm-B/B', U1 snRNPA (U1A) and U1-70kDa autoantigens. The results are in accordance with the clustering of the predicted HLA class-I and class-II epitopes in protein parts which encompass the consensus of ordered regions, determined by individual disorder predictors. Some HLA class-II epitopes and linear B-cell epitopes were located near the segments predicted to have elevated crystallographic B factor in EBNA-1, Sm-B/B' and U1 snRNP A proteins, suggesting that protein flexibility could influence the structural availability of epitopes. Naturally processed T-cell epitopes and linear B-cell epitopes could also be found within putative disordered binding sites, determined by "dips" in the prevalently disordered parts of prediction profiles of the majority of disorder predictors, and peaks in ANCHOR-prediction profile. Two minor antigenic regions within EBNA-1, mapped to the residues 58-85 and 398-458, encompassing putative disordered binding sites, contain epitopes connected with anti-Ro 60kDa and anti-Sm B/B' autoimmunity in systemic lupus erythematosus. One of these regions overlaps residues 395-450, identified as the binding site of USP7 (HAUSP), which regulates the EBNA-1 replication function. In Sm-B/B', one of the putative disordered binding sites (residues 114-165) encompasses the T-cell epitope 136-153, while another, residues 200-216, flanks two proline-rich B-cell epitopes (residues 190-198 and 216-222), overlapping the preferred CD2BP2-GYF-binding motif (R/K/G)XXPPGX(R/K), characteristic of splicosomal proteins. We have noticed that the same motif (residues 397-403) is mimicked in EBNA-1 and overlaps epitope 398-404, involved in anti-Sm B/B' autoimmunity. The majority of recognized T- and B-cell epitopes in analyzed autoantigens or tumor-associated antigens appertain to the ordered or transient protein structures. The congruence between certain B- and T-cell epitopes and predicted disordered binding sites or protein-binding eukaryotic motifs in the antigens participating in molecular complexes might influence the capture of antigens, their processing and subsequent presentation and immunodominance.
authors.affiliation: University of Belgrade, Institute of General and Physical Chemistry, Studentski trg 12/V, Belgrade, Serbia. Electronic address: mpavlovic@iofh.bg.ac.rs.
authors.forename: Mirjana D
authors.initials: MD
authors.lastname: Pavlović
authors.affiliation: University of Belgrade, Faculty of Mechanical Engineering, Kraljice Marije 16, Belgrade, Serbia. Electronic address: djandrlic@mas.bg.ac.rs.
authors.forename: Davorka R
authors.initials: DR
authors.lastname: Jandrlić
authors.affiliation: University of Belgrade, Faculty of Mathematics, P.O.B. 550, Studentski trg 16, Belgrade, Serbia. Electronic address: nenad@matf.bg.ac.rs.
authors.forename: Nenad S
authors.initials: NS
authors.lastname: Mitić
mesh_terms: D000951:Antigens, Neoplasm / Q000737:chemistry / Q000378:metabolism; D001402:B-Lymphocytes / Q000276:immunology*; D018604:Epitope Mapping / Q000379:methods*; D018985:Epitopes, B-Lymphocyte / Q000737:chemistry / Q000378:metabolism; D018984:Epitopes, T-Lymphocyte / Q000737:chemistry / Q000378:metabolism; D019309:Epstein-Barr Virus Nuclear Antigens / Q000737:chemistry / Q000378:metabolism; D006680:HLA Antigens / Q000378:metabolism; D006801:Humans; D007111:Immunity, Cellular; D008180:Lupus Erythematosus, Systemic / Q000276:immunology*; D008297:Male; D009363:Neoplasm Proteins / Q000737:chemistry / Q000378:metabolism; D010455:Peptides / Q000737:chemistry / Q000378:metabolism; D010750:Phosphoproteins / Q000737:chemistry / Q000378:metabolism; D011485:Protein Binding; D011487:Protein Conformation; D017412:Ribonucleoprotein, U1 Small Nuclear / Q000737:chemistry / Q000378:metabolism; D013329:Structure-Activity Relationship; D013601:T-Lymphocytes / Q000276:immunology*; D013736:Testicular Neoplasms / Q000276:immunology*; D015534:Trans-Activators / Q000737:chemistry / Q000378:metabolism
chemical_list: D000951:Antigens, Neoplasm; D018985:Epitopes, B-Lymphocyte; D018984:Epitopes, T-Lymphocyte; D019309:Epstein-Barr Virus Nuclear Antigens; D006680:HLA Antigens; C095204:MAGEA4 protein, human; D009363:Neoplasm Proteins; D010455:Peptides; D010750:Phosphoproteins; D017412:Ribonucleoprotein, U1 Small Nuclear; C090236:SM protein, Human herpesvirus 4; D015534:Trans-Activators; C075339:U1A protein; C417029:EBV-encoded nuclear antigen 1
keywords: Autoimmunity; Cancer; Disorder prediction; Disordered binding sites; Epitope structural availability; T-cell epitope prediction